Trial · NCT04828005
Participant flow84
How many started, completed or left each group, period by period.
1 to 20 of 84
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part 1 Setup: 1st Treatment (1 Day) | STARTED | Part 1 Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 7 | |
| Part 1 Setup: 1st Treatment (1 Day) | STARTED | Part 1 Extension Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | STARTED | Part 2: Intranasal Nalmefene Crossover to Intranasal Naloxone | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | STARTED | Part 2: Intranasal Naloxone Crossover to Intranasal Nalmefene | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | COMPLETED | Part 1 Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 7 | |
| Part 1 Setup: 1st Treatment (1 Day) | COMPLETED | Part 1 Extension Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | COMPLETED | Part 2: Intranasal Nalmefene Crossover to Intranasal Naloxone | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | COMPLETED | Part 2: Intranasal Naloxone Crossover to Intranasal Nalmefene | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | NOT COMPLETED | Part 1 Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | NOT COMPLETED | Part 1 Extension Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | NOT COMPLETED | Part 2: Intranasal Nalmefene Crossover to Intranasal Naloxone | 0 | |
| Part 1 Setup: 1st Treatment (1 Day) | NOT COMPLETED | Part 2: Intranasal Naloxone Crossover to Intranasal Nalmefene | 0 | |
| Part 1 Setup: Washout (4 Days) | STARTED | Part 1 Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 7 | |
| Part 1 Setup: Washout (4 Days) | STARTED | Part 1 Extension Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 0 | |
| Part 1 Setup: Washout (4 Days) | STARTED | Part 2: Intranasal Nalmefene Crossover to Intranasal Naloxone | 0 | |
| Part 1 Setup: Washout (4 Days) | STARTED | Part 2: Intranasal Naloxone Crossover to Intranasal Nalmefene | 0 | |
| Part 1 Setup: Washout (4 Days) | COMPLETED | Part 1 Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 5 | |
| Part 1 Setup: Washout (4 Days) | COMPLETED | Part 1 Extension Setup (Ventilation Model): Remifentanil, Then Intranasal Naloxone | 0 | |
| Part 1 Setup: Washout (4 Days) | COMPLETED | Part 2: Intranasal Nalmefene Crossover to Intranasal Naloxone | 0 | |
| Part 1 Setup: Washout (4 Days) | COMPLETED | Part 2: Intranasal Naloxone Crossover to Intranasal Nalmefene | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04828005/flow